Business Standard

Advanced Enzyme surges 12% as Nalanda India Equity Fund ups stake by 3%

Advanced Vital Enzymes Private Limited, the promoter of Advanced Enzyme Technologies, has offloaded 2.57 million equity shares at a price of Rs 270.04 per share

Between December 2020 and February 2021, traders were supposed to maintain at least 25 per cent of the peak margin
Premium

Between December 2020 and February 2021, traders were supposed to maintain at least 25 per cent of the peak margin

SI Reporter Mumbai
Shares of Advanced Enzyme Technologies surged 12 per cent to Rs 298 on the National Stock Exchange (NSE) in Tuesday's intra-day trade after Nalanda India Equity Fund increased its stake by nearly 3 per cent stake in the company.

On September 20, 2022, Nalanda India Equity Fund purchased 2.91 million equity shares, representing 2.6 per cent stake in Advanced Enzyme Technologies, worth Rs 78.62 crore via block deal, NSE data shows. The foreign portfolio investor bought shares at weighted average price of Rs 270.03 per share, data shows.

Advanced Vital Enzymes Private Limited, the promoter of Advanced Enzyme

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in